ImmunologybioRxiv
A novel biparatopic antibody-ACE2 fusion that blocks SARS-CoV-2 infection: implications for therapy
X. Miao, Y. Luo, X. Huang…·Y. Xu
The paper develops a biparatopic antibody-ACE2 fusion (89C8-ACE2) that effectively blocks SARS-CoV-2 infection in vitro and neutralizes authentic virus at low nanomolar concentrations.
DOI 10.1080/19420862.2020.1804241